Englebardt Samuel Eli 4

What Happened
Director Samuel E. Englebardt was granted a total of 71,258 deferred stock units (DSUs) on June 4, 2026. The filing shows two awards of 35,629 units each: one tranche priced at $4.21 per unit (total value $149,998) and a second tranche recorded at $0.00. These are awards/compensation (not purchases or sales) and represent contingent rights to receive Class A common shares under the company’s DSU arrangements.

Key Details

• Transaction date: 2026-06-04; Form filed 2026-06-05 (timely).
• Grants reported: 35,629 DSUs at $4.21 (value $149,998) and 35,629 DSUs at $0.00.
• Shares owned after transaction: the filing corrects a prior Form 4 (see F2) to reflect the accurate total holdings; the exact post-transaction total is reported on the Form 4.
• Footnotes of note:
  • F1: One DSU tranche represents DSUs in lieu of cash compensation; vesting in equal quarterly installments beginning March 31, 2026; settlement deferred until separation, change in control, death, or disability.
  • F3: The other DSU tranche vests in full on the earlier of June 4, 2027 or the 2027 annual meeting; settlement similarly deferred.
  • F2: Corrects an immaterial prior reporting error in total securities beneficially owned.
• Filing timeliness: reported promptly (filed next day).

Context
DSUs are deferred-compensation awards that give the holder a contingent right to receive company shares in the future; they do not result in immediate stock ownership or open-market buying/selling. Vesting and settlement rules (see footnotes) determine when the units convert to actual shares. Such grants are commonly used for director compensation and are routine—informative about pay structure but not necessarily a market sentiment signal.